adesso AG November 5, 2012

Size: px
Start display at page:

Download "adesso AG November 5, 2012"

Transcription

1 WGZ adesso BANK AG RESEARCH November 5, 2012 p. 1 Update November 5, 2012 Recommendation: Buy Company data before: Hold as of 08/16/12 Sector IT Target price (EUR) 8.90 Market segment General Standard Share price (Xetra) (EUR) 6.74 ISIN DE000A0Z23Q5 11/02/12 5:30 PM Reuters ADNGk.DE Share price potential 32% Bloomberg ADN1 Higher licence revenues and successful restructuring At the end of last week, adesso posted preliminary Q3 figures. After the weak Q2 figures, the Q3 figures were a positive surprise. Quarterly sales increased to EUR30m (26.1; Q2 2012: 28.9) thus beating our forecast of EUR28.9m due to higher licence revenues of FirstSpirit (in-house developed content management system). According to preliminary figures, EBITDA increased to EUR2.5m (1.8; Q2 2012: 0.1) and thus were clearly higher than our forecast of EUR1.9m. We have raised our full-year forecast after the preliminary Q3 figures were posted: sales 2012E: EUR115.5m (before: 114.4); EBITDA 2012E: EUR5.4m (before: 4.5). When figures were posted the company pointed out that especially the EBITDA company forecast will very likely be beaten. When the Q2 figures were posted, adesso had revised its own sales forecast to EUR m (before: ) and EBITDA forecast to EUR m (before: ). As part of a revaluation of the adesso share, we raise our price target to EUR8.90 (before: 7.30; DCF/peer group valuation). We newly recommend to Buy (before: Hold). Share data Shares (m) Freefloat 35.4% Market cap. (EURm) 38.7 Trading volume (shares) 1,860 52W High 03/23/12 EUR W Low 08/19/11 EUR5.60 Termine Final Q2 figures 08/28/12 Q3 figures 11/13/12 Performance absolute relative to DAX 1M 14.2% 14.8% 3M -0.9% -7.6% 6M -6.4% -16.6% 12M -0.7% -19.6% Index weighting CDAX 0.002% Sales Sales growth - 6.8% 20.1% 23.7% 9.0% 8.1% EBITDA EBITDA margin 12.1% 8.1% 6.5% 8.1% 4.7% 7.3% Net income Net margin 6.3% 4.9% 2.8% 3.9% -0.2% 3.4% EPS DPS Net financial debt/ebitda Net Gearing Free cash flow (EUR) FCF per share (EUR) EV / sales EV / EBITDA EV / EBIT EV / FCF 3.9 neg neg. 9.4 P/E neg. 9.2 P/B Dividend yield 0.0% 2.9% 2.6% 2.8% 2.7% 3.0% Figures in EURm except EPS, DPS and FCF per share (EUR), Source: ; own estimates /07 11/08 11/09 11/10 11/11 11/12 Source: Bloomberg Contact Research Department Head: Dr. Frank Wohlgemuth, CIIA/CEFA Equity Sales Team +49 (0) Thomas Aldenrath / thomas.aldenrath@wgzbank.de Jörg Eberhardt / joerg.eberhardt@wgzbank.de Oliver Garbe / oliver.garbe@wgzbank.de Ansgar Krekeler / ansgar.krekeler@wgzbank.de Alexander Lachmann / alexander.lachmann@wgzbank.de Thomas Reher / thomas.reher@wgzbank.de Peter Richards / peter.richards@wgzbank.de Udo Zartner / udo.zartner@wgzbank.de Author: Matthias Engelmayer (analyst) Please notice the indications concerning the preparation of this document, the indications concerning potential conflicts of interest, the compulsory information required by paragraph 34b WpHG 1)2)3)4)6) (Wertpapierhandelsgesetz Please notice - Securities the advice Trade regarding Act) and the possible liability declaration conflicts at the of end interests of this document. as well This as financial the disclaimer analysis in the at meaning the end of paragraph of this document 34b WpHG shall only be distributed to professional clients or eligible counterparties according to 31a WpHG.

2 November 5, 2012 p. 2 In addition to the positive topline development in the software (FirstSpirit) and IT consulting business (higher level of utilisation in the consulting business due to positive market environment and higher number of work days) successful restructuring caused an income improvement in the energy and water management segment. After the end of the development of the software project dynamic.suite (in-house software solution for the (municipal) energy and water management) and the lack of further operating losses the break-even point was reached in Q at subsidiary evu.it (SAP business for energy utilities) after loss-making preceding quarters. We estimate that these two effects caused an income increase by over EUR1m. Further positive income effects came from the successively declining burdens from the unprofitable fixed-price contract and business figures above plan at ARITHNEA (e-business specialist; expansion of content management system activities). The preliminary Q3 figures show that the expanding - and compared to IT consulting more profitable - software business and the licence revenues generated make it more difficult to forecast the business development. In addition to the low valuation level (P/B ratio 2012E: 1.1; P/E ratio 2013E: 9.2) the attractive dividend yield of 2.7% favours the adesso share. With regard to the high capital position and liquid funds (net cash of EUR4.4m as of June 30, 2012) a stable dividend of EUR0.18 per share is to be expected for despite the decreased income compared to Successful restructuring of the energy and water management business Business development above plan at ARITHNEA (Volatile) software revenues make forecast difficult Attractive dividend yield

3 November 5, 2012 p. 3 Valuation Conclusion of the valuation Our valuation of the adesso share is based on a DCF model and a peer group analysis. The DCF model calculates a fair value of EUR8.96 (before: 7.77) per share (raised 2012 and 2013 estimates; EBIT 2013E: EUR6.9m (before: 5.8) and the peer group analysis of EUR8.92 (before: 7.01) per share. Weighting the DCF model and peer group analysis at 50% each, we have calculated a fair value of EUR8.94 (before: 7.39) per share. The (average) fair value corresponds to a P/E ratio 2013E of Fair value of EUR8.94 (before: 7.39) per adesso share DCF model EURm 2012E 2013E 2014E 2015E 2016E 2017E 2018E 2019E 2020E 2021E Sales Growth y/y - 8.1% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% EBIT margin 2.5% 5.5% 6.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% EBIT Income taxes Amortisation and depreciation /- Change in long-term provisions /- Others (e.g. minority interests) Gross operating cash flow /+ Change in net working capital Investments in fixed assets Free cash flow Present values Total present values (2012E-2021E) 12.2 Terminal value 23.3 in % of total value: 71% Value of operating business 35.4 Model parameters + Cash and cash equivalents Financial debt/pension provisions -6.5 Target capital structure Equity 80% Financial debt 20% Fair market value of equity 51.5 Risk-free rate: 4.0% Beta: 1.3 Risk prem. debt: 2.0% Risk prem.: 5.0% Tax shield: 30.0% Number of shares outstanding (m) 5.7 Cost of equity: 10.7% Cost of debt: 4.2% Fair value per share (EUR) 8.96 Source: own estimates Growth FCF (TV): 2.0% WACC: 9.4% Date: 11/05/2012 Sensitivity analysis (EUR) Discount rate (WACC) 8.9% 9.4% 9.9% 10.4% 2.0% % % % Source: own estimates Growth FCF (TV)

4 November 5, 2012 p. 4 Peer group analysis P/E EV/EBIT EV/EBITDA 2012E 2013E 2012E 2013E 2012E 2013E Allgeier Holding GFT Technologies SQS Software Quality Systems COR&FJA neg neg Seven Principles neg. 8.7 neg Mean Median neg Figures in EURm, only EPS in EUR EPS EBIT EBITDA 2012E 2013E 2012E 2013E 2012E 2013E Enterprise value (EV) Liquid assets Financial liabilities Fair market capitalisation Number of shares (units m) Fair value n/a Average value Weighting Fair value per share (EUR) 8.92 Source: own estimates; Bloomberg Closing prices as of 11/02/2012

5 November 5, 2012 p. 5 Appendix Profit and loss statement EURm Sales Other internally generated assets Other operating income Gross profit Costs of material Personnel costs Other operating expenses EBITDA Depreciatin on property, plant and equipment Depreciation on goodwill EBIT Income from investments Other financial result Interest income and similar income Interest expenses and similar expenses EBT Income taxes Net income Share of minority interests Net income after minorities Number of shares (unit) EPS (undiluted, EUR) EPS (diluted, EUR) Source: ; own estimates Profit and loss statement (as % of sales) Sales 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% Other internally generated assets 0.0% 0.0% 0.0% 0.9% 0.5% 0.0% Other operating income 3.5% 3.0% 1.6% 1.6% 2.2% 1.2% Gross profit 103.5% 103.0% 101.6% 102.5% 102.7% 101.2% Costs of material -9.6% -11.2% -11.0% -12.5% -12.3% -12.1% Personnel costs -60.1% -63.6% -63.7% -61.8% -65.7% -61.8% Other operating expenses -21.6% -20.1% -20.3% -20.0% -20.0% -20.0% EBITDA 12.1% 8.1% 6.5% 8.1% 4.7% 7.3% Depreciatin on property, plant and equipment -5.4% -3.9% -3.4% -1.9% -2.2% -1.8% Depreciation on goodwill 0.0% 0.0% 0.0% -1.3% 0.0% 0.0% EBIT 6.7% 4.2% 3.1% 4.9% 2.5% 5.5% Income from investments 0.0% 0.0% 0.0% 0.0% -2.1% 0.0% Other financial result 0.0% 0.5% 0.0% 0.0% 0.0% 0.0% Interest income and similar income 0.8% 0.5% 0.2% 0.2% 0.2% 0.2% Interest expenses and similar expenses -0.6% -0.5% -0.5% -0.3% -0.4% -0.4% EBT 6.9% 4.6% 2.9% 4.7% 0.3% 5.2% Income taxes -0.5% 0.4% 0.0% -1.0% -0.1% -1.2% Net income 6.4% 5.0% 2.9% 3.7% 0.2% 4.0% Share of minority interests -0.1% -0.1% -0.1% 0.2% -0.4% -0.7% Net income after minorities 6.3% 4.9% 2.8% 3.9% -0.2% 3.4% Source: ; own estimates

6 November 5, 2012 p. 6 Balance sheet EURm Intangible assets Goodwill Property, plant and equipment Financial assets Other assets Receivables from income taxes Deffered taxes Non-current assets Trade accounts receivable Receivables PoC Receivables from income taxes Financial assets Other assets Fiduciary held cash on hand and at bank Cash on hand and at bank Current assets Assets Subscribed capital Capital reserve Other retained earnings Reserve for currency conversion Consolidated earnings Minority share Equity Financial liabilities Pernsion and similar liabilities Provisions Other non-current liabilities Deferred taxes liabilities Non-current liabilities Financial liabilities Trade accounts payable Liabilities PoC Liabilities from income taxes Provisions Other current liabilities Current liabilities Liabilities Source: ; own estimates

7 November 5, 2012 p. 7 Balance sheet (as % of sales) Intangible assets 7.4% 6.6% 4.9% 4.2% 2.4% 1.5% Goodwill 11.8% 21.0% 20.2% 16.5% 24.1% 23.1% Property, plant and equipment 1.7% 1.7% 1.9% 2.0% 1.7% 1.4% Financial assets 0.8% 0.5% 0.5% 0.3% 0.3% 0.2% Other assets 0.4% 0.4% 0.4% 0.4% 2.6% 2.5% Receivables from income taxes 0.1% 0.1% 0.1% 0.1% 0.0% 0.1% Deffered taxes 9.2% 9.7% 9.5% 9.7% 9.3% 9.5% Non-current assets 31.4% 40.1% 37.6% 33.2% 40.3% 38.3% Trade accounts receivable 17.1% 24.2% 27.5% 27.3% 31.2% 31.3% Receivables PoC 8.5% 3.7% 5.0% 5.2% 5.3% 5.2% Receivables from income taxes 1.4% 1.2% 1.2% 0.7% 0.0% 0.8% Financial assets 0.1% 0.4% 0.4% 0.1% 0.1% 0.1% Other assets 0.7% 0.9% 0.9% 1.4% 1.4% 1.4% Fiduciary held cash on hand and at bank 7.3% 0.0% 0.0% 0.0% 0.0% 0.0% Cash on hand and at bank 33.5% 29.4% 27.3% 32.2% 21.7% 22.9% Current assets 68.6% 59.9% 62.4% 66.8% 59.7% 61.7% Assets 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% Subscribed capital 71.7% 9.7% 9.2% 8.2% 7.8% 7.5% Capital reserve -41.8% 18.7% 17.8% 16.3% 15.6% 14.9% Other retained earnings 7.6% 14.2% 17.7% 17.9% 22.1% 21.2% Reserve for currency conversion 0.2% 0.2% 0.7% 0.8% 0.8% 0.8% Consolidated earnings 7.7% 6.1% 4.0% 5.6% 0.3% 6.6% Minority share 0.1% 0.1% 0.3% 0.4% 1.5% 1.4% Equity 45.4% 49.0% 49.6% 49.2% 48.1% 52.4% Financial liabilities 3.8% 9.5% 8.8% 5.2% 10.8% 8.3% Pernsion and similar liabilities 0.9% 0.8% 0.8% 0.8% 0.9% 0.9% Provisions 0.3% 0.6% 0.5% 0.7% 0.7% 0.8% Other non-current liabilities 0.0% 0.0% 0.0% 0.2% 0.2% 0.2% Deferred taxes liabilities 3.1% 2.5% 1.9% 2.0% 0.1% 2.3% Non-current liabilities 8.0% 13.4% 12.0% 8.9% 12.7% 12.5% Financial liabilities 9.5% 5.1% 3.5% 3.2% 2.7% 2.6% Trade accounts payable 7.9% 6.5% 5.7% 8.9% 9.5% 9.8% Liabilities PoC 5.2% 3.6% 3.6% 2.9% 2.7% 2.6% Liabilities from income taxes 1.7% 1.2% 0.6% 1.9% 0.1% 2.2% Provisions 3.4% 2.7% 2.4% 2.1% 2.2% 2.3% Other current liabilities 18.9% 18.6% 22.6% 23.0% 21.8% 15.6% Current liabilities 46.6% 37.6% 38.4% 41.9% 39.1% 35.1% Liabilities 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% Source: ; own estimates

8 November 5, 2012 p. 8 Cash flow statement EURm EBT Income from financing and investment activities Depreciation and amortization on PP&E and intangible assets Expenses from the disposal of PP&E Other non-cash income Change in pension provisions Change in other provisions Tax payments Cash earnings Change to net operating assets Cash flow from operating activities Disinvestments of PP&E Payments-in for investments in intangible assets Change of cash and cash equivalents from the disposal / deconsolidation of consolidated companies Change in cash and cash equivalents from initial consolidation Payments for investments in PP&E Payments for investments in intangible assets Cash flow from investment activities Dividend payments Capital increase Acquisition of minority interests Repayment of liabilities from finance leases New liabilities to banks Repayment of financial liabilities Payment from other financial loans received Interest paid Interest received Cash flow from financing activities Change in cash and cash equivalents Currency differences Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Source: ; own estimates

9 November 5, 2012 p. 9 Key figures Growth analysis Sales growth - 6.8% 20.1% 23.7% 9.0% 8.1% EBITDA growth % -2.8% 53.8% -37.2% 67.6% EBIT growth % -11.2% 93.6% -43.6% 136.0% EBT growth % -25.3% 103.5% -93.4% 1,883.6% EPS growth (diluted) % -32.3% 74.4% n/a n/a Margin analysis EBITDA margin 12.1% 8.1% 6.5% 8.1% 4.7% 7.3% EBIT margin 6.7% 4.2% 3.1% 4.9% 2.5% 5.5% EBT margin 6.9% 4.6% 2.9% 4.7% 0.3% 5.2% Net margin 6.3% 4.9% 2.8% 3.9% -0.2% 3.4% Yield analysis ROI 7.6% 6.1% 3.9% 6.3% -0.3% 5.6% ROCE 17.0% 11.1% 7.5% 10.7% 5.3% 11.2% ROE 16.7% 13.0% 8.0% 12.8% -0.7% 11.5% ROIC 12.5% 9.1% 6.9% 10.0% 5.2% 11.1% Balance sheet analysis Equity ratio 45.4% 49.0% 49.6% 49.2% 48.1% 52.4% Equty / LT assets ratio 144.5% 122.1% 132.0% 148.4% 119.5% 137.1% Equity + LT debt / LT assets ratio 170.0% 124.2% 134.2% 150.9% 121.6% 139.3% Asset intensity 31.4% 40.1% 37.6% 33.2% 40.3% 38.3% Debtor turnover Debtor terms / -days Working capital / sales ratio 10.4% 12.2% 14.6% 13.7% 14.0% 14.5% Days of payables outstanding (days) Debt ratios Net financial debt Net financial debt / EBITDA Net gearing EBITDA interest coverage EBIT interest coverage Cash flow analysis Free cash flow (FCF) FCF / sales 11.6% -3.7% 4.2% 7.8% -5.4% 3.3% FCF / net income 182.6% -75.3% 152.6% 199.5% % 97.8% FCF per share (EUR) FCF yield 25.4% -9.1% 11.0% 22.1% -16.3% 10.7% Capex (EURm) Capex / Depreciation and amortization 19.2% 179.5% 19.8% 94.0% 322.0% 115.1% Capex / sales 1.0% 6.9% 0.7% 1.8% 7.0% 2.0% Valuation multiples EV / sales EV / EBITDA EV / EBIT EV / FCF 3.9 neg neg. 9.4 P/E ratio neg. 9.2 P/B ratio P/CF ratio neg. 5.5 P/S ratio neg. 0.3 Dividend yield 0.0% 2.9% 2.6% 2.8% 2.7% 3.0% Source: ; own estimates

10 November 5, 2012 p. 10 Sales development Sales by region (2011) % 20% 15% 20% % 5% 80% 0 0% Sales (EURm) Change y/y IT Services IT Solutions High double-digit growth rates since 2009; 2012 forecast includes sales impact from company's majority takeover of ARITHNEA CAGR E of 13% IT Services segment still dominating (80% (2010: 86%) of group sales) Above average sales growth in software business Earnings development (EURm) ROE % 16% 14% 12% 10% 8% 6% 4% 2% 0% -2% EBITDA EBIT Equity excl. minorities (EURm) ROE Volatile earnings development in the past years; CAGR EBIT E: 9% Expansion of software business leads to higher economies of scale ROE level of the past years in the low double-digit area; ROE 2013E: 11.5% Shareholders' equity 2012E of EUR34.2m equal to P/B ratio of 1.1 Operating cash flow (EURm) Net cash Operating cash flow Net working capital Net cash (EURm) - left axes Net cash / EBITDA - right axes Extraordinary high operating cash flow in 2011 (EUR10.2m) - positive impact due to working capital reduction Operating cash flow 2012E: EUR-2.4m Strength of operating cash flow traditionally leads to high net cash position; decrease in 2012 because of the majority stake in ARITHNEA Net cash position to continue the buy-and-build strategy Source: adesso; own estimates

11 November 5, 2012 p. 11 Peer group companies in EURm except EPS Share price Market cap EV Sales EBITDA EBIT EPS 2012E 2013E 2012E 2013E 2012E 2013E 2012E 2013E Allgeier Holding Growth (sales) or margin (EBITDA, EBIT) 19.9% 5.8% 6.4% 2.6% 3.6% - - GFT Technologies Growth (sales) or margin (EBITDA, EBIT) -0.3% 5.1% 5.8% 4.4% 5.1% - - SQS Software Quality Systems Growth (sales) or margin (EBITDA, EBIT) 8.0% 8.0% 8.8% 4.8% 5.8% - - COR&FJA Growth (sales) or margin (EBITDA, EBIT) 5.0% 2.9% 4.4% -0.2% 1.3% - - Seven Principles Growth (sales) or margin (EBITDA, EBIT) 6.7% 1.4% 5.0% -0.1% 3.4% - - Source: Bloomberg Closing prices as of 11/02/2012

12 November 5, 2012 p. 12 Disclaimer Recommendations concerning particular shares Buy: Hold: Sell: According to our assessment, the stock should register an absolute profit of at least 15% within a 6-month period. According to our assessment, the stock should register an absolute profit between 0 and 15% within a 6-month period. According to our assessment, the stock should register an absolute loss within a 6-month period. Compulsory information required under 34b of the German Securities Trading Law (WpHG) and the Financial Analysis Regulation Key sources of information Key sources of information used in the preparation of this document are publications in foreign and domestic media such as information services (e.g. Reuters, VWD, Bloomberg, DPA-AFX etc.), the financial press (e.g. Börsenzeitung, Handelsblatt, FAZ, FTD, Wall Street Journal, Financial Times etc.), specialised journals, published statistics, rating agencies and publications of the issuers analysed. Summary of the evaluation principles used: Analyses of shares: In valuing companies standard and accepted valuation methods (amongst others the Discounted Cash Flow Method (DCF Method), Peer-Group Analysis) are applied. Under the DCF Method the capitalised value of the issuers is calculated which shows the sum of the discounted company results, i.e. the current value of the issuer s future net distributions. The capitalised value is therefore determined with reference to the anticipated future company results and the capitalisation yield applied. Under the Peer-Group Analysis Method issuers quoted on the Stock Exchange are valued with reference to the comparison of ratio indices (e.g. share price / profit ratio, share price / book value ratio, enterprise value / sales, enterprise value / EBITDA, enterprise value / EBIT). The comparability of the ratio indices is determined above all by business activity and commercial prospects. Sensitivity of the evaluation parameters: The figures taken from the income statement, the cash-flow statement and the balance sheet upon which the evaluation of companies is based are numerical estimates and therefore subject to risks. These may change at any time without prior notice. Quite apart from the evaluation method applied, there exists a very real risk that the share price goal may not be reached in the anticipated period of time. These risks include unforeseen changes in competitive pressure or in the demand for the issuer s products. Such fluctuations in demand may arise as a result of changes of a technological nature, the overall level of economic activity or in some cases as a result of changes in business moral concepts. Changes in tax law, in currency exchange rates and, in certain business segments, in regulations are further factors which can influence evaluations. This discussion of evaluation methods and risk factors makes no claim to be exhaustive.

13 November 5, 2012 p. 13 Timing conditions of planned up-dates: Analyses of shares: The WGZ BANK maintains a list of issuers for whom company-based financial analyses ( Cover list of share analyses ) are published. The criterion for the inclusion or removal of an issuer from this list is governed primarily by the company s inclusion in an index (DAX and EuroStoxx 50 SM ). In addition, selected issuers from the mid and small cap segment or from the US markets are included. In such cases the inclusion or removal of these issuers from the cover list is at the sole discretion of the WGZ BANK. Generally, a short expert commentary together with a summary and evaluation of current events specific to the company is prepared every week for the issuers included on the cover list share analyses. Moreover, every day company-specific events such as, for example, ad hoc announcements or important news relating to individual companies on the cover list are evaluated. The decision as to which issuers are covered by such publications is at the sole discretion of the WGZ BANK. Moreover, fundamental analyses are prepared for the issuers included on the cover list. The decision as to which issuers are covered by such publications is at the sole discretion of the WGZ BANK. It may occur at any time that, in fulfilment of the provisions of the Securities Trading Law, the publication of financial analyses of individual issuers included in the cover list are blocked without any prior warning. Internal organisational measures to deal with the prevention or handling of conflicts of interest: Employees of the WGZ BANK who are involved with the preparation and / or the offering of financial analyses are subject to the company s internal compliancy regulations which classifies them as employees of an area requiring confidentiality. The company s internal compliancy regulations are in line with the provisions of the Guideline for the Concretisation of Organisational Obligations of Companies Trading in Securities in accordance with 33 and 33b of the Securities Trading Law (WpHG). Possible conflicts of interest as at: 11/05/2012 The WGZ BANK and/or its affiliated companies hold shares of the issuer analysed in their trading portfolio. Further possible conflicts of interest are indicated as follows: The WGZ BANK and/or its affiliated companies: 1) own at least 1% of the issuers share capital. 2) were involved within the last twelve months in the management of a consortium issuing financial instruments of the issuer by way of a public offer. 3) look after financial instruments of the issuer in a market through the placement of buying or selling orders. 4) have within the last twelve months concluded an agreement with issuers, which are either themselves or through their financial instruments the object of a financial analysis, covering services related to investment banking transactions or have received a service or a promise of services in such an agreement. 6) have concluded an agreement with the issuers which are either themselves or through their financial instruments the object of the financial analysis regarding the preparation of the financial analysis. As at: 11/05/2012 WGZ BANK AG Responsible supervisory authority: Westdeutsche Genossenschafts-Zentralbank Federal Authority for the Supervision of Financial Services Ludwig-Erhard-Allee 20 (Bundesanstalt für Finanzdienstleistungsaufsicht) D Düsseldorf Graurheindorfer Str. 108, Bonn and Marie-Curie-Straße 24-28, Frankfurt am Main

14 November 5, 2012 p. 14 Liability declaration This document is for information purposes only. It has been prepared by WGZ BANK AG, Westdeutsche Genossenschafts-Zentralbank ("WGZ BANK") and shall be distributed in Germany, Austria, Luxembourg, and Switzerland. This document is not directed to people or companies domiciled and/or maintaining branch-offices in any other country, particularly in the United States of America, Canada, the United Kingdom, and Japan. This document shall only be distributed according to the applicable laws of the respective country. People receiving this document, i.e. this information and material, shall be obliged to inform themselves about the applicable laws of the respective country and to act accordingly. This document constitutes neither an offer nor an invitation to subscribe to or to purchase a security. Especially with preparation of this document WGZ BANK shall not act as an investment consultant or neither acts on the basis of some asset management duty or obligation. Any investment decision regarding any security or other financial instruments should be based on individual, professional advice, independent investment analysis and processes, and/or the relevant (securities) prospectus or information memorandum, but not on this document. Depending on particular investment objectives, the investment horizon, and the individual financial situation, a given financial instrument may not or not fully be appropriate for individual investors. For complete information about the respective securities and financial instruments, especially binding terms and conditions as well as risks, and information about the issuer, please refer to the relevant (securities) prospectus or information memorandum. This document constitutes an independent assessment of the respective issuer and/or the negotiable securities by WGZ BANK. All and any herein contained assessments, opinions and statements are those of the author of this document and do not necessarily reflect the opinion of the issuer or third parties. All and any information this document is based on has been taken from resources considered as reliable, but has not necessarily been verified by WGZ BANK. WGZ BANK therefore does not warrant the accuracy, completeness and correctness of the information and opinions contained herein. WGZ BANK assumes no responsibility or liability for direct or indirect damage arising from the use or distribution of this document or of the information contained therein or which otherwise may arise from it. The information, opinions and statements represent the status quo of the day of the preparation of the document. Future developments may render them out of date without any changes made to this document. WGZ BANK is not obliged to update this document. Price movements experienced in the past, simulations or forecasts are no reliable indicators for future price movements of securities. Price targets set for any company analysed in this report may not be achieved due to various risk factors including but not limited to market volatility, sector volatility, measures taken by the company, the economic situation, failure to meet earnings and/or revenue targets, unavailability of complete and accurate information, and/or a subsequent event that has an effect on the underlying assumptions made by WGZ BANK or other sources used by WGZ BANK in the preparation of this report. During the analysis period WGZ BANK has the right to publish another report about the company which does not include a price target but a discussion of valuation criteria. Any price targets set should be seen in the context of all previously released reports and developments concerning the company as well as the sector and financial markets in which it operates. The tax treatment of financial instruments depends on the individual circumstances of the respective investor and may be subject to future changes, which may be retroactive. WGZ BANK has the right to maintain investment banking and other business relations with the company/companies analysed in this report. The research analysts of WGZ BANK too provide important input for investment banking and other methods for the selection of companies. Investors should assume that WGZ BANK and/or its affiliates are seeking or will seek investment banking or other business with the subject company/companies of this report, and that the research analysts involved in the preparation of this report may be instrumental in the arrangement of such business to the extent permitted by applicable law. WGZ BANK and/or its affiliates as well as their employees may hold positions in these securities or effect transactions in these securities. Research analysts do not receive remuneration for particular investment banking transactions. The author/authors of this report receives/ receive remuneration based on, among other things, the total profitability of WGZ BANK, which includes earnings from the investment banking business and the company's other business segments. On principle, the analysts of WGZ BANK and the members of their household as well as any person reporting to the analysts must have no pecuniary interest in financial instruments of the company covered by the analyst. As far as WGZ BANK provides hyperlinks to websites of companies mentioned in this report, the inclusion of a given hyperlink shall not mean that WGZ BANK confirms, recommends or authorises all and any data on the respective website or data that can be accessed from the website. WGZ BANK assumes no liability for such data nor for any consequences arising from the use of same. This document is subject to copyright of WGZ BANK and may not, in whole or in part, be reproduced, copied, made available to others, or published without prior written consent from WGZ BANK.

adesso AG MAY 31, 2012

adesso AG MAY 31, 2012 WGZ BANK AG RESEARCH MAY 31, 2012 p. 1 AG MAY 31, 2012 Recommendation: Buy Company data before: - as of - Sector IT Target price (EUR) 9.20 Market segment General Standard Share price (Xetra) (EUR) 6.70

More information

Research Note. Fair Value REIT-AG

Research Note. Fair Value REIT-AG Independent Research Unabhängige Finanzmarktanalyse GmbH Research Note Fair Value REIT-AG Preliminary results 2011 Please take note of the information concerning the preparation of this document, the informa-tion

More information

Solid preliminary FY 2014 results released. Net asset value increased by 3.5% in H 2014 with difficult trading environment

Solid preliminary FY 2014 results released. Net asset value increased by 3.5% in H 2014 with difficult trading environment A cc or # $T ypcap$ 1628 1 0 4 2 Equity flash Trading Update Financial Services Scherzer & Co. AG BUY (BUY) Target 1.80 EUR (1.80 EUR) Price (last closing price) : 1.56 EUR Upside : 15% Est.. change 2015e

More information

Borussia Dortmund GmbH & Co. KGaA

Borussia Dortmund GmbH & Co. KGaA A cc or # 6 $T ypcap$ 1628 1 0 4 2 Page 1/7 Equity flash Trading Update Entertainment BUY (BUY) Target EUR 5.00 (EUR 5.00) Price (last closing price) : EUR 3.91 Upside : 28% Est. change 2015e 2016e EPS

More information

BUY (previous: BUY) (previous: 77.50)

BUY (previous: BUY) (previous: 77.50) November 10, 2017 Information Analysis Analyst: Daniel Grossjohann +49 69 71 91 838-42 Daniel.grossjohann@bankm.de Evaluation result Fair value BUY 75.65 (previous: BUY) (previous: 77.50) Find BankM Research

More information

Financials/Prime Standard

Financials/Prime Standard EquityStory Financials/Prime Standard Neutral, PT EUR 27.50 upside 5.8% EquityStory report unspectacular Q1 figures 2012 figures as expected; proposes increased dividend to EUR0.70 and issues 2012 guidance

More information

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A FIRST BERLIN Equity Research HAEMATO AG RATING Germany / Pharma 2017 Frankfurt PRICE TARGET 7.40 Bloomberg: HAE GR Prelims Return Potential 25.4% ISIN: DE0006190705 Risk Rating High SOLID UPTICK IN H2

More information

Electronics Line 3000 Ltd.

Electronics Line 3000 Ltd. June 18, 2013 Information Analysis Analysts Dr. Roger Becker, CEFA David Szabadvari +49 69 71 91 838-46, -48 roger.becker@bankm.de, david.szabadvari@bankm.de Evaluation result Fair value BUY 0.88 (previous

More information

Buy PT EUR24,00, upside 23%

Buy PT EUR24,00, upside 23% Ludwig Beck AG Consumers & Retail Buy PT EUR24,00, upside 23% Positive start into 2012 Q1 meets our expectations and backs our call Ludwig Beck shares have outperformed the SDAX by 1% y-o-y as the SDAX

More information

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected B a sl er A G # $T ypcap$ 1576 14 1 1 x 6495 2 Page 1/6 First Take Reco. lowered Neutral vs Buy Electronics Germany Neutral Target price : 60.00 EUR vs 52.00 EUR Price (11/01/2016) : 58.04 EUR Upside :

More information

MATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation

MATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation Update Note Price as of 21/02/13: 4 24 February 2014 Company / Sector Fair Value Recommendation InVision 49.0 Buy Technology: Cloud Computing ( 34) (Buy) Excellent margin trend in Prelims Share price performance

More information

BDI BioEnergy Internat Buy

BDI BioEnergy Internat Buy 13/08/12 13/10/12 13/12/12 13/02/13 13/04/13 13/06/13 13/08/13 13/10/13 13/12/13 13/02/14 13/04/14 13/06/14 13/08/14 MATELAN Research Update Note Price as of 13/08/14: 10.29 14 August 2014 Company / Sector

More information

Geratherm Medical AG Strong demand in Q3

Geratherm Medical AG Strong demand in Q3 Solventis Wertpapierhandelsbank Research Research 23 November 2009 Klaus Schlote Klaus Soer Tel.: +49 (0) 69-71589151 Tel.: +49 (0) 69-71589152 kschlote@solventis.de ksoer@solventis.de Ulf van Lengerich

More information

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F FIRST BERLIN Equity Research SFC Energy AG RATING Germany / Energy Preliminary Primary exchange: Frankfurt PRICE TARGET 8.70 Bloomberg: F3C GR 2017 figures Return Potential 13.3% ISIN: DE0007568578 Risk

More information

PA Power Automation AG

PA Power Automation AG February 08, 2017 Information Analysis Analysts: Daniel Großjohann, Dr. Roger Becker, CEFA +49 69 71 91 838-42, -46 daniel.grossjohann@bankm.de, roger.becker@bankm.de Evaluation result Fair value HOLD

More information

Klaus Kränzle, Please inform yourself of important disclosures and disclaimers in the appendix

Klaus Kränzle, Please inform yourself of important disclosures and disclaimers in the appendix research Note Consumer & Retail Target price decomposition Consensus SQR (adjust.) 19 October 2012 Neutral, PT EUR25,00, upside 5% published Q3 figures and is optimistic for financial year 2012 - guidance

More information

NOT RATED. (previously Buy) (previously 1.73) adj. net (mln ) DPS ( ) adj. EPS ( )

NOT RATED. (previously Buy) (previously 1.73) adj. net (mln ) DPS ( ) adj. EPS ( ) 7 September 2010 Information analysis Analyst Dr. Roger Becker, CEFA, Biologist +49 69 71 91 838-46 roger.becker@bankm.de Evaluation result NOT RATED Fair value (previously Buy) (previously 1.73) Sales

More information

Strong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG

Strong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG 18 Mai 2017 EQS Group AG Rating Buy (Buy) Share price (EUR) 52.50 Target price (EUR) 60.00 (50.00) Bloomberg Sector EQS GY Technology Share data Shares out (m) 1.3 Daily volume shs (m) 0.0 Free float (%)

More information

Borussia Dortmund GmbH & Co. KGaA

Borussia Dortmund GmbH & Co. KGaA A cc or # $T ypcap$ 1628 1 0 4 2 Page 1/7 Equity flash Trading Update Entertainment BUY (BUY) Target EUR 6.00 (EUR 6.00) Price (last closing price) : EUR 3.94 Upside : 52% E.st. change 2015e 2016e EPS

More information

HOLD 51,85. (previous: Hold) (previous: 51,65)

HOLD 51,85. (previous: Hold) (previous: 51,65) August 12, 2015 Information Analysis Analyst Daniel Großjohann +49 69 71 91 838-42 daniel.grossjohann@bankm.de Evaluation result Fair value HOLD 51,85 (previous: Hold) (previous: 51,65) BankM Research

More information

Intershop Communications AG

Intershop Communications AG FIRST BERLIN Equity Research Intershop Communications AG RATING GERMANY / Technology Primary Exchange: Frankfurt Q2 figures PRICE TARGET 1.44 Bloomberg: ISH2 GR Return Potential -15.2% ISIN: DE000A0EPUH1

More information

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following FIRST BERLIN Equity Research M1 Kliniken AG RATING Germany / Healthcare Facilities & Services Update following Frankfurt PRICE TARGET 16.50 Bloomberg: M12 GR capital increase Return Potential 44.7% ISIN:

More information

Key ratios Sales adj. net

Key ratios Sales adj. net Date 07/30/2012 Vara Research GmbH Schweizer Straße 13 60594 Frankfurt am Main www.vararesearch.de Buy (formerly: Buy) Design Hotels AG TP: 0.95 (formerly: 0.90) Changes No signs of economic slowdown at

More information

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research PNE WIND AG RATING Germany / Cleantech Primary exchange: Frankfurt Q1/16 figures PRICE TARGET 3.30 Bloomberg: PNE3 GR Return Potential 50.1% ISIN: DE000A0JBPG2 Risk Rating

More information

PA Power Automation AG

PA Power Automation AG September 29, 2017 Information Analysis Analysts: Daniel Großjohann, Dr. Roger Becker, CEFA +49 69 71 91 838-42, -46 daniel.grossjohann@bankm.de, roger.becker@bankm.de Evaluation result NOT RATED - Fair

More information

Evaluation result Fair value DPS. adj. net. adj. EPS ( )

Evaluation result Fair value DPS. adj. net. adj. EPS ( ) May 27, 2010 Information analysis Evaluation result Fair value Analyst BUY 1.73 Dr. Roger Becker, CEFA, Biologist +49 69 71 91 838-46 roger.becker@bankm.de (previously BUY) (previously 1.73) Acquisition

More information

CLERE AG DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER. FIRST BERLIN Equity Research. Delisting & PRICE TARGET C L

CLERE AG DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER. FIRST BERLIN Equity Research. Delisting & PRICE TARGET C L CLERE AG RATING Germany / Cleantech Delisting & Primary exchange: XETRA PRICE TARGET 16.33 Bloomberg: CAG GR takeover bid Return Potential 1.8% ISIN: DE0005215107 Risk Rating Medium DELISTING & TAKEOVER

More information

HOLD (previous: BUY) (previous: 68.00)

HOLD (previous: BUY) (previous: 68.00) February 23, 2017 Information Analysis Analyst Daniel Großjohann +49 69 71 91 838-42 daniel.grossjohann@bankm.de Evaluation Result Fair Value HOLD 69.00 (previous: BUY) (previous: 68.00) BankM Research

More information

18 October 2016 aventron AG. FIRST BERLIN Equity Research

18 October 2016 aventron AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research aventron AG RATING Switzerland / Renewable Energy Berner Börse H1 figures PRICE TARGET CHF13.00 Bloomberg: AVEN SW Return Potential 47.7% ISIN: CH0023777235 Risk Rating medium

More information

Advanced Vision Techn Buy

Advanced Vision Techn Buy 16/9/13 16/11/13 16/1/14 16/3/14 16/5/14 16/7/14 16/9/14 16/11/14 16/1/15 16/3/15 16/5/15 16/7/15 MATELAN Research Update Note Closing price as of 13/8/15: 9.16 14 August 215 Company / Sector Fair Value

More information

TEMPORARILY NO VALUATION. (previous: not rated)

TEMPORARILY NO VALUATION. (previous: not rated) 23. Dezember 2013 Information analysis Analysts Dr. Roger Becker, CEFA David Szabadvari +49 69 71 91 838-46, -48 roger.becker@bankm.de, david.szabadvari@bankm.de Valuation Result TEMPORARILY NO VALUATION

More information

ISRA VISION Neutral

ISRA VISION Neutral Update Note Closing price as of 1/8/17: 142.8 4 September 217 Company / Sector Fair Value Recommendation ISRA VISION 128. Neutral Technology: Machine Vision ( 128.) (unchanged) Solid Q3 leaves company

More information

Buy PT 24,00, upside 23%

Buy PT 24,00, upside 23% Ludwig Beck AG Consumers & Retail Buy PT 24,00, upside 23% FY2011 comes in as expected dividend increased - positive outlook for 2012 Ludwig Beck shares have outperformed the SDAX by 11% y-o-y. The company

More information

All for One Steeb AG August 13, 2013

All for One Steeb AG August 13, 2013 August 13, 2013 Information analysis Analyst Daniel Großjohann, Benjamin Ludacka +49 69 71 91 838-42, +49 69 71 91 838-41 daniel.grossjohann@bankm.de, benjamin.ludacka@bankm.de Strategic acquisitions as

More information

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research ISARIA Wohnbau AG RATING Germany / Real estate Frankfurt Q1/16 Results PRICE TARGET 5.70 Bloomberg: IWB GR Return Potential 71.8% ISIN: DE000A1E8H38 Risk Rating High SLOW Q1

More information

Leifheit AG. Management Meeting confirms our positive view. Buy (Buy) EUR (60.00 EUR ) BANKHAUS LAMPE // 1 16/02/2016

Leifheit AG. Management Meeting confirms our positive view. Buy (Buy) EUR (60.00 EUR ) BANKHAUS LAMPE // 1 16/02/2016 BANKHAUS LAMPE // 1 Leifheit AG Management Meeting confirms our positive view 16/02/2016 Buy (Buy) 60.00 EUR (60.00 EUR ) Close 12/02/2016 45.00 EUR Bloomberg: LEI GY WKN: 646450 Sector Consumer Share

More information

HAEMATO AG MARKET SHARE WIN IN PARALLEL IMPORT BUSINESS. FIRST BERLIN Equity Research H1/18 PRICE TARGET H A

HAEMATO AG MARKET SHARE WIN IN PARALLEL IMPORT BUSINESS. FIRST BERLIN Equity Research H1/18 PRICE TARGET H A FIRST BERLIN Equity Research HAEMATO AG RATING Germany / Pharma H1/18 Frankfurt PRICE TARGET 7.60 Bloomberg: HAE GR results Return Potential 41.8% ISIN: DE0006190705 Risk Rating High MARKET SHARE WIN IN

More information

Tel.: +49 (0) Tel.: +49 (0)

Tel.: +49 (0) Tel.: +49 (0) Solventis Wertpapierhandelsbank Research 25 th August 2014 Klaus Schlote Ulf van Lengerich Tel.: +49 (0) 6131 48 60 651 Tel.: +49 (0) 6131 48 60 654 kschlote@solventis.de ulengerich @solventis.de Geratherm

More information

HOLD (previous: Hold) (previous: 51.85)

HOLD (previous: Hold) (previous: 51.85) January 26, 2016 Information Analysis Analyst Daniel Großjohann +49 69 71 91 838-42 daniel.grossjohann@bankm.de Evaluation Result Fair Value HOLD 65.00 (previous: Hold) (previous: 51.85) BankM Research

More information

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium. August 18 th 2014 Share price: NOK 21.70 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg Health Care COVI.OL COV:NO Market Cap (NOKm) 167.9 Net debt (NOKm) -28.6 EV

More information

ad pepper media International N.V.

ad pepper media International N.V. FIRST BERLIN Equity Research ad pepper media International N.V. RATING The Netherlands / Internet Services Frankfurt Final 2017 figures PRICE TARGET 4.80 Bloomberg: APM GR Return Potential 30.4% ISIN:

More information

18 November 2016 Energiekontor AG. FIRST BERLIN Equity Research

18 November 2016 Energiekontor AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research Energiekontor AG RATING Germany / Cleantech Frankfurt Stock Exchange 9M report PRICE TARGET 19.70 Bloomberg: EKT GR Return Potential 31.3% ISIN: DE0005313506 Risk Rating High

More information

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview Equity Research Quick Bite Preview 22 October 2013 Air France-KLM Q3 due 31 October More restructuring needed Supported by lower fuel costs and the ramp up in cost savings, we expect Q3 to deliver a solid

More information

6 September 2016 aventron AG. FIRST BERLIN Equity Research

6 September 2016 aventron AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research aventron AG RATING Switzerland / Renewable Energy Berner Börse Capital increase PRICE TARGET CHF13.00 Bloomberg: AVEN SW Return Potential 52.8% ISIN: CH0023777235 Risk Rating

More information

24 September 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research

24 September 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research OpenLimit Holding AG RATING Switzerland / Software Primary exchange: Frankfurt H1 figures PRICE TARGET 0.50 Bloomberg: O5H GR Return Potential 72.4% ISIN: CH0022237009 Risk

More information

Indygotech Minerals S.A.

Indygotech Minerals S.A. Indygotech Minerals S.A. Fair Value: n.a. Update Rating: n.a Indygotech Minerals (IDG) share price has recently taken a hit. The reason was a delay of completion of the production facilities for ceramic

More information

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N FIRST BERLIN Equity Research PNE WIND AG RATING Germany / Cleantech Good start to Primary exchange: Frankfurt PRICE TARGET 3.00 Bloomberg: PNE3 GR the new year Return Potential 43.8% ISIN: DE000A0JBPG2

More information

Evaluation result Fair value BUY (prev.: BUY) (prev.: 21.52)

Evaluation result Fair value BUY (prev.: BUY) (prev.: 21.52) September 05, 2013 Information Analysis Evaluation result Fair value Analysts Dr. Roger Becker, CEFA David Szabadvari +49 69 71 91 838-46, -48 roger.becker@bankm.de, david.szabadvari@bankm.de Solid Growth,

More information

Evaluation Result Fair Value BUY (previous: BUY) (previous: 65.50)

Evaluation Result Fair Value BUY (previous: BUY) (previous: 65.50) January 23, 2017 Information Analysis Evaluation Result Fair Value Analyst Daniel Großjohann +49 69 71 91 838-42 daniel.grossjohann@bankm.de BUY 68.00 (previous: BUY) (previous: 65.50) BankM Research on

More information

ContextVision. Expecting solid results and awaiting progress update on research program

ContextVision. Expecting solid results and awaiting progress update on research program 1Q17 Preview (report due April 27 th ) April 24 th 2017 Share price: NOK 61.75 Target: NOK 100.00 (unchanged) Risk: Medium ContextVision Key share data Sector Reuters Bloomberg Health Care COVI.OL COV

More information

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS FIRST BERLIN Equity Research SFC Energy AG RATING Germany / Energy Final Primary exchange: Frankfurt PRICE TARGET 11.20 Bloomberg: F3C GR 2018 figures Return Potential 13.1% ISIN: DE0007568578 Risk Rating

More information

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24.

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24. 3Q14 Results analysis November 5 th 2014 Share price: NOK 22.00 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg ContextVision is a market making client of Norne Securities

More information

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research Energiekontor AG RATING Germany / Cleantech Frankfurt Stock Exchange 9M report PRICE TARGET 24.80 Bloomberg: EKT GR Return Potential 75.1% ISIN: DE0005313506 Risk Rating High

More information

Price Target: EUR 4.15 (3.80)

Price Target: EUR 4.15 (3.80) Recommendation: BUY (BUY) Risk: MEDIUM (MEDIUM) Price Target: EUR 4.15 (3.80) 08 December 2010 Increased guidance Share price (dark) vs. CDAX and higher price target Last week M.A.X. increased its guidance

More information

26 April 2017 aventron AG. FIRST BERLIN Equity Research

26 April 2017 aventron AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research aventron AG RATING Switzerland / Renewable Energy Berner Börse 2016 annual figures PRICE TARGET CHF 13.00 Bloomberg: AVEN SW Return Potential 42.9% ISIN: CH0023777235 Risk

More information

5 September 2016 OTI Greentech AG. FIRST BERLIN Equity Research

5 September 2016 OTI Greentech AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research OTI Greentech AG RATING Germany / Cleantech Exchange: Duesseldorf Preliminary H1 figures PRICE TARGET 1.90 Bloomberg: NSA GR Return Potential 280.0% ISIN: DE000A0HNE89 Risk

More information

BUY (previous: BUY) (previous: 72.30) DPS ( ) adj. EPS ( )

BUY (previous: BUY) (previous: 72.30) DPS ( ) adj. EPS ( ) January 14, 2019 Information Analysis Analyst: Daniel Grossjohann +49 69 71 91 838-42 Daniel.grossjohann@bankm.de Evaluation result Fair value BUY 70.60 (previous: BUY) (previous: 72.30) Find BankM Research

More information

PrimeCity Investment Plc

PrimeCity Investment Plc A cc or # $TypCap$ 1628 1 0 4 2 Page 1/8 Equity flash Trading Update Real Estate BUY (BUY) Target 5.60 EUR (5.60 EUR) Price (last closing price) : 3.40 EUR Upside : 65 % Est. change 2015e 2016e FFO I PS

More information

Adler Real Estate AG. Fewer vacancies, more properties. Buy (Buy) EUR (16.50 EUR ) BANKHAUS LAMPE // 1 28/03/2017

Adler Real Estate AG. Fewer vacancies, more properties. Buy (Buy) EUR (16.50 EUR ) BANKHAUS LAMPE // 1 28/03/2017 BANKHAUS LAMPE // 1 Adler Real Estate AG Fewer vacancies, more properties 28/03/2017 Buy (Buy) 17.00 EUR (16.50 EUR ) Close 24/03/2017 13.92 EUR Bloomberg: ADL GY WKN: 500800 Sector Share price performance

More information

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research Energiekontor AG RATING Germany / Cleantech Frankfurt Stock Exchange 2017 final figures PRICE TARGET 23.50 Bloomberg: EKT GR Return Potential 72.2% ISIN: DE0005313506 Risk

More information

14 August 2017 PNE WIND AG. FIRST BERLIN Equity Research

14 August 2017 PNE WIND AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research PNE WIND AG RATING Germany / Cleantech Primary exchange: Frankfurt Q2 figures PRICE TARGET 3.50 Bloomberg: PNE3 GR Return Potential 33.5% ISIN: DE000A0JBPG2 Risk Rating High

More information

BUY (previous: BUY) (previous: 3.70)

BUY (previous: BUY) (previous: 3.70) October 22, 2015 Information Analysis Analysts Dipl.-Kfm. Stefan Scharff, CREA Dr. Roger Becker, CEFA +49 69 71 91 838-43, -46 stefan.scharff@bankm.de, roger.becker@bankm.de Evaluation result Fair value

More information

2014 E 2015 E 2016 E 2017 E

2014 E 2015 E 2016 E 2017 E Equity Research 4 December 2014 Interpump Group Hydraulics M&A may power growth Rating BUY Target price EUR13 Interpump is up 25% since the beginning of the year, bolstered by strong interim results and

More information

7C Solarparken GUIDANCE FOR 2016 INCREASED. FIRST BERLIN Equity Research. Preliminary 2014 PRICE TARGET 2.10

7C Solarparken GUIDANCE FOR 2016 INCREASED. FIRST BERLIN Equity Research. Preliminary 2014 PRICE TARGET 2.10 FIRST BERLIN Equity Research 12 7C Solarparken AG 7 RATING Germany / Cleantech Preliminary 2014 Primary Exchange: Frankfurt PRICE TARGET 2.10 Bloomberg: HRPK GF figures Return Potential 13.9% ISIN: DE000A11QW68

More information

14 September 2017 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 216.5% ISIN: NL

14 September 2017 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 216.5% ISIN: NL FIRST BERLIN Equity Research Pharming Group NV Netherlands / Biotechnology Primary exchange: Euronext Amsterdam / Secondary exchange: Frankfurt Update Bloomberg: PHARM NA Return Potential 216.5% ISIN:

More information

FinTech Group. Buy TP 38 (from 30) CP (Closing 3 May 2018) Ready for accelerated growth in Equity Research Quick Bite

FinTech Group. Buy TP 38 (from 30) CP (Closing 3 May 2018) Ready for accelerated growth in Equity Research Quick Bite Equity Research Quick Bite FinTech Group Ready for accelerated growth in 2018 2017 results met management guidance. Our focus is on growth in 2018 with net income guidance of 24m implying 43% y/y growth

More information

!""(old: EUR 20.90) This report is intended for Unauthorized redistribution of this report is prohibited.

!(old: EUR 20.90) This report is intended for Unauthorized redistribution of this report is prohibited. (old: Buy) 29-Mai-18!""(old: EUR 20.90) EUR 21.90 #$ Q2 18: 28.09.18 A7A@GR %&' EUR 113.4 m Simon.Bentlage@ha-ib.de A7AGN.DE '( EUR 109.2 m Tel.: +49 40 4506 342 3096 ')*!*+' FinLab AG (FinLab) is a German

More information

The growth story continues

The growth story continues MBB SE 8 September 2016 The growth story continues quirin bank Equity Research Rating Buy (Buy) Share price (EUR) 39.99 Target price (EUR) 45.00 (38.00) Bloomberg Sector Share data MBB GY Industrial Holding

More information

-for professional clients only-

-for professional clients only- 29 April 2016 -for professional clients only- Retail & Consumer Goods CEWE VAT increase for Photobooks? Market Weight Old: Overweight Target price: 59.80 Old: 66.30 Current price: (28 April 2016) 57.60

More information

EQUINET INVESTIGATOR

EQUINET INVESTIGATOR Hypoport 2 January 211 Financials Bloomberg: HYQ GR Market Cap: EUR 72m Free Float: 35% Current Share Price: EUR 11.8 Buy / Target EUR 17 Profile Hypoport is an internet-based financial services provider

More information

Advanced Vision Technology

Advanced Vision Technology FIRST BERLIN Equity Research Advanced Vision Technology Ltd RATING Israel / Machine Vision Technology Q3/16 Primary exchange: Frankfurt PRICE TARGET 11.70 / $12.70 Bloomberg: VSJ GR Results Return Potential

More information

LUCISANO MEDIA GROUP. New partner for Lucisano. Buy (maintained) Company Update

LUCISANO MEDIA GROUP. New partner for Lucisano. Buy (maintained) Company Update LUCISANO MEDIA GROUP Company Update Buy (maintained) 5:30PM MARKET PRICE: EUR2.82 TARGET PRICE: EUR3.40 (unchanged) Entertainment Data Shares Outstanding (m): 14.88 Market Cap. (EURm): 41.96 Enterprise

More information

5 November C Solarparken AG. FIRST BERLIN Equity Research

5 November C Solarparken AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research 5 7C Solarparken AG 7 RATING Germany / Cleantech Primary Exchange: Frankfurt Next growth phase PRICE TARGET 3.00 Bloomberg: HRPK GF Return Potential 30.4% ISIN: DE000A11QW68

More information

BUY (previous: BUY) (previous: 75.65)

BUY (previous: BUY) (previous: 75.65) January 16, 2018 Information Analysis Analyst: Daniel Grossjohann +49 69 71 91 838-42 Daniel.grossjohann@bankm.de Evaluation result Fair value BUY 76.40 (previous: BUY) (previous: 75.65) Find BankM Research

More information

Price Target: EUR (22.00)

Price Target: EUR (22.00) Recommendation:.% vs. BUY (BUY) Risk: MEDIUM (MEDIUM) Price Target: EUR 22.00 (22.00) 26 August 2011 2H11 outlook on track to achieve goals The share s downside trend is over Share price (dark) vs. CDAX

More information

24 May 2016 Energiekontor AG. FIRST BERLIN Equity Research

24 May 2016 Energiekontor AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research Energiekontor AG RATING Germany / Cleantech Frankfurt Stock Exchange Q1 update PRICE TARGET 18.00 Bloomberg: EKT GR Return Potential 30.3% ISIN: DE0005313506 Risk Rating High

More information

Price Target: EUR (17.00)

Price Target: EUR (17.00) Recommendation: BUY (BUY) Risk: HIGH (HIGH) Price Target: EUR 17.00 (17.00) 20 March 2012 Margins drag behind better than expected top-line Schwäbisch Hall AG introduced as new partner of GENOPACE Hypoport

More information

adesso AG Germany - IT Services

adesso AG Germany - IT Services Germany - IT Services Buy (old: Buy) 11-May-11 Price target: EUR 11.00 (old: EUR 10.00) Tim Wunderlich Price: EUR 6.96 Next result: Q2 2011: 26.08.11 Bloomberg: ADN1 GR Market cap: EUR 40.0 m tim.wunderlich@ha-research.de

More information

adesso AG Germany - IT Services

adesso AG Germany - IT Services Germany - IT Services Buy (old: Buy) 09-March-12 Price target: EUR 14.00 (old: EUR 12.50) Tim Wunderlich Price: EUR 7.20 Next result: Q4 2011: 30.03.12 Bloomberg: ADN1 GR Market cap: EUR 41.1 m tim.wunderlich@ha-research.de

More information

- 2/7 - Segment Discussion August 05, Segment Discussion. Stock and Valuation

- 2/7 - Segment Discussion August 05, Segment Discussion. Stock and Valuation August 05, 2011 Information Analysis Analyst Dr. Roger Becker, CEFA, Biologist +49 69 71 91 838-46 roger.becker@bankm.de Evaluation result Fair value BUY 38.30 (previously BUY) (previously 40.50) H1/2011:

More information

18 January 2018 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 45.9% ISIN: NL

18 January 2018 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 45.9% ISIN: NL FIRST BERLIN Equity Research Pharming Group NV Netherlands / Biotechnology Primary exchange: Euronext Amsterdam / Secondary exchange: Frankfurt Update Bloomberg: PHARM NA Return Potential 45.9% ISIN: NL0010391025

More information

25 April 2014 OpenLimit Holding AG. FIRST BERLIN Equity Research

25 April 2014 OpenLimit Holding AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research OpenLimit Holding AG RATING Switzerland / Software Primary exchange: Frankfurt FY 2013 figures PRICE TARGET 1.30 Bloomberg: O5H GR Return Potential 90.1% ISIN: CH0022237009

More information

INDRA SPAIN \ TECHNOLOGY

INDRA SPAIN \ TECHNOLOGY INDRA SPAIN \ TECHNOLOGY Company Update NR (prev. Buy) Target: 14.5 (prev. 17) Risk: High STOCK DATA Price 13.97 Bloomberg Code IDR SM Market Cap. ( mn) 2,269 Free Float 59.31% Shares Out. (mn) 162 52-week

More information

Petro Rabigh Shutdown marred Q2 results

Petro Rabigh Shutdown marred Q2 results PETROR AB: Saudi Arabia US$5.07bn 17.4% US$11.19mn Market cap Free float Avg. daily volume RSI10 Vol th Target price n/a n/a Consensus price 32.18 48.3% over current Current price 21.70 as at 17/8/2011

More information

Zain KSA bogged down by high debt

Zain KSA bogged down by high debt Vol th RSI10 Zain KSA ZAINKSA AB: Saudi Arabia US$2.464bn 48.3% US$16.50mn Market cap Free float Avg. daily volume Target price 7.30 12.31% over current Consensus price 7.62 17.2% over current Current

More information

6 June 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 44.2% ISIN: DE000A1EWVY8

6 June 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 44.2% ISIN: DE000A1EWVY8 FIRST BERLIN Equity Research Formycon AG RATING Germany / Biopharmaceuticals Xetra Q1 2018 results PRICE TARGET 53.00 Bloomberg: FYB GR Return Potential 44.2% ISIN: DE000A1EWVY8 Risk Rating High FORMYCON

More information

Aroundtown SA LATEST RUN RATES CONFIRM GROWTH PHASE. FIRST BERLIN Equity Research. Operational PRICE TARGET Ar ou

Aroundtown SA LATEST RUN RATES CONFIRM GROWTH PHASE. FIRST BERLIN Equity Research. Operational PRICE TARGET Ar ou FIRST BERLIN Equity Research Aroundtown SA RATING Germany / Real Estate Operational Frankfurt Stock Exchange PRICE TARGET 8.20 Bloomberg: AT1 GR update Return Potential 26.1% ISIN: LU1673108939 Risk Rating

More information

Sandpiper Digital Payments AG

Sandpiper Digital Payments AG December 18th, 2018 Research Comment Sandpiper Digital Payments AG Investment portfolio becomes more focused Rating: Speculative Buy (unchanged) Price: 0.072 Euro Price target: 0.22 Euro Analyst: Dipl.-Kfm.

More information

Saudi Ceramic Expansion plan key growth driver

Saudi Ceramic Expansion plan key growth driver RSI10 Construction and Materials Industrial SCERCO AB: Saudi Arabia Rating NEUTRAL Target price SAR116. 0 (4.5% upside) Current SAR111.3 price Key themes & implications Company is one of the leading ceramic

More information

Reduced EPS but smart acquisition

Reduced EPS but smart acquisition 23 Oktober 2017 MBB SE Rating Buy Share price (EUR) 99.55 Target price (EUR) 130.00 Bloomberg MBB GY Sector - Share data Shares out (m) 6.6 Daily volume shs (m) 1.0 Free float (%) 35.20 Market cap (EUR

More information

14 November 2018 M1 Kliniken AG. FIRST BERLIN Equity Research. H1/18 figures &

14 November 2018 M1 Kliniken AG. FIRST BERLIN Equity Research. H1/18 figures & FIRST BERLIN Equity Research M1 Kliniken AG RATING Germany / Healthcare Facilities & Services H1/18 figures & Frankfurt PRICE TARGET 19.20 Bloomberg: M12 GR capital increase Return Potential 57.4% ISIN:

More information

INNOFACTOR. Danish country manager suspected misconduct led to assessment error in financials. IT Services 21 October Result Comment NO RATING

INNOFACTOR. Danish country manager suspected misconduct led to assessment error in financials. IT Services 21 October Result Comment NO RATING INNOFACTOR IT Services 21 October 2015 - Result Comment NO RATING PRICE Innofactor 0,78 Price as of 19.10.2015 High/Low 12m 1,17 / 0,76 COMPANY DATA Mcap 26 EV 36 No. of shares (out) 33,5 No. of shares

More information

IFRS Financial Ratios

IFRS Financial Ratios 100 IFRS Financial Ratios Authors Ulrich Wiehle Michael Diegelmann Henryk Deter Dr. Peter Noel Schömig Michael Rolf 100 IFRS Financial Ratios cometis publishing GmbH & Co. KG, Unter den Eichen 7, 65195

More information

26 October 2017 Energiekontor AG. FIRST BERLIN Equity Research. Update. Bloomberg: EKT GR Return Potential 67.2% ISIN: DE

26 October 2017 Energiekontor AG. FIRST BERLIN Equity Research. Update. Bloomberg: EKT GR Return Potential 67.2% ISIN: DE FIRST BERLIN Equity Research Energiekontor AG RATING Germany / Cleantech Frankfurt Stock Exchange Update PRICE TARGET 25.00 Bloomberg: EKT GR Return Potential 67.2% ISIN: DE0005313506 Risk Rating High

More information

S&T AG Austria - IT Services

S&T AG Austria - IT Services Austria - IT Services Buy (old: Buy) 03-November-14 Price target: EUR 4.40 (old: EUR 4.40) Tim Wunderlich, CFA Price: EUR 2.74 Next result: Q3 2014: 04.11.13 Bloomberg: SANT GR Market cap: EUR 118.5 m

More information

BUY (previous: BUY) (previous: 2.20)

BUY (previous: BUY) (previous: 2.20) May 04, 2017 Basic Report Update Analyst: Dr. Roger Becker, CEFA, Biologist +49 69 71 91 838-46 roger.becker@bankm.de Evaluation result Fair value BUY 2.26 (previous: BUY) (previous: 2.20) Find BankM Research

More information

19 December 2016 NOXXON Pharma NV. FIRST BERLIN Equity Research. Cooperation

19 December 2016 NOXXON Pharma NV. FIRST BERLIN Equity Research. Cooperation FIRST BERLIN Equity Research NOXXON Pharma NV RATING Germany / Biotechnology Cooperation Paris PRICE TARGET 40.00 Bloomberg: ALNOX FP agreement closed Return Potential 81.9% ISIN: NL0012044762 Risk Rating

More information

18 May 2018 Pharming Group NV. FIRST BERLIN Equity Research

18 May 2018 Pharming Group NV. FIRST BERLIN Equity Research FIRST BERLIN Equity Research Pharming Group NV 18 P ha Netherlands / Biotechnology RATING BUY Primary exchange: Euronext Amsterdam / Secondary exchange: Frankfurt Q1 results PRICE TARGET 2.00 Bloomberg:

More information

Price Target: EUR (20.60) 07 April 2011 Solid FY10 & More to come

Price Target: EUR (20.60) 07 April 2011 Solid FY10 & More to come Recommendation: BUY(BUY) Risk: HIGH (HIGH) Price Target: EUR 20.60 (20.60) 07 April 2011 Solid FY10 & More to come Final FY10 results: On 31 March 2011 Vectron announced final FY10 results which confirmed

More information

Yansab Better than expected results

Yansab Better than expected results YANSAB AB: Saudi Arabia US$6.91bn 39.8% US$23.37mn Market cap Free float Avg. daily volume RSI10 Vol th Target price n/a n/a Consensus price 56.00 21.5% over current Current price 46.10 as at 9/2/2011

More information